Binnopharm Group
PrivateLast Round
Debt
Sep 26, 2025
Est. Valuation
$857.14M
Total Funding Raised
$275.37M
Company Overview
Binnopharm Group is a pharmaceutical company that produces a wide range of medicines, including prescription and over-the-counter drugs, active pharmaceutical ingredients, and veterinary medicines.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Binnopharm Group Comps
Public and private peers based on sector, stage, and business model.
Binnopharm Group Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Sep 26, 2025 | ||||
| Debt | Jul 8, 2025 | ||||
| Debt | Mar 19, 2025 | ||||
| Debt | Feb 6, 2025 | ||||
| Strategic | Jun 29, 2021 | ||||
M&A | Apr 1, 2013 |
Binnopharm Group Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MKB | Debt |
| VTB Capital | Strategic |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 14, 2026
Plans to acquire Akrikhin announced by Russian drugmaker.
Binnopharm Group Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Binnopharm Group's valuation, stock price, and market status.
